certify

Anca Spanu Anca's career in journalism spans over 2 decades. She has served as staff writer, editor and deputy chief editor at various media outlets all over the world. At Healthcare Weekly, Anca writes about current events, innovations in the healthcare space and events/ conferences with a focus on investing & startups.

March 24, 2021 1539 Views
Positive results proving an overall survival (OS) benefit from the Phase 3 trial investigating Sanofi and Regeneron’s PD-1 ...
banner
Adsense